Next Article in Journal
Undersampling in Orthogonal Frequency Division Multiplexing Telecommunication Systems
Next Article in Special Issue
CERN-MEDICIS (Medical Isotopes Collected from ISOLDE): A New Facility
Previous Article in Journal
Diffraction Focal Position and Vector Diffraction Theory for Micro Holographic Storage Systems
Previous Article in Special Issue
Dry Distillation of Radioiodine from TeO2 Targets
Article Menu

Export Article

Open AccessArticle
Appl. Sci. 2014, 4(1), 66-78; doi:10.3390/app4010066

Radiosynthesis and in Vivo Evaluation of Two PET Radioligands for Imaging α-Synuclein

Department of Radiology, Washington University School of Medicine, 510 S. Kingshighway Boulevard, St. Louis, MO 63110, USA
Department of Neurology, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO 63110, USA
Author to whom correspondence should be addressed.
Received: 30 April 2013 / Revised: 7 February 2014 / Accepted: 27 February 2014 / Published: 17 March 2014
(This article belongs to the Special Issue Radioisotope Production and Applications)
View Full-Text   |   Download PDF [535 KB, uploaded 17 March 2014]   |  


Two α-synuclein ligands, 3-methoxy-7-nitro-10H-phenothiazine (2a, Ki = 32.1 ± 1.3 nM) and 3-(2-fluoroethoxy)-7-nitro-10H-phenothiazine (2b, Ki = 49.0 ± 4.9 nM), were radiolabeled as potential PET imaging agents by respectively introducing 11C and 18F. The syntheses of [11C]2a and [18F]2b were accomplished in a good yield with high specific activity. Ex vivo biodistribution studies in rats revealed that both [11C]2a and [18F]2b crossed the blood-brain barrier (BBB) and demonstrated good brain uptake 5 min post-injection. MicroPET imaging of [11C]2a in a non-human primate (NHP) confirmed that the tracer was able to cross the BBB with rapid washout kinetics from brain regions of a healthy macaque. The initial studies suggested that further structural optimization of [11C]2a and [18F]2b is necessary in order to identify a highly specific positron emission tomography (PET) radioligand for in vivo imaging of α-synuclein aggregation in the central nervous system (CNS). View Full-Text
Keywords: Lewy bodies; Parkinson’s disease; PET; phenothiazine; radiosynthesis; α-synuclein Lewy bodies; Parkinson’s disease; PET; phenothiazine; radiosynthesis; α-synuclein

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Zhang, X.; Jin, H.; Padakanti, P.K.; Li, J.; Yang, H.; Fan, J.; Mach, R.H.; Kotzbauer, P.; Tu, Z. Radiosynthesis and in Vivo Evaluation of Two PET Radioligands for Imaging α-Synuclein. Appl. Sci. 2014, 4, 66-78.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Appl. Sci. EISSN 2076-3417 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top